pending 2022 EP4544052A1
Treatment of GPAM Related Diseases and Disorders
Inventors: Gregory McInnes
Plain Language Summary
Compositions comprising oligonucleotides (siRNA or ASO) that target GPAM for the treatment of metabolic disorders including liver disorders and cardiovascular conditions.
RNA Therapeutics